I dyremodeller er samtidig administration af Neulasta og 5- fluorouracil (5- FU) eller andre antimetabolitter blevet vist at øge myelosuppression.
In animal models concomitant administration of Neulasta and 5-fluorouracil (5-FU) or other antimetabolites has been shown to potentiate myelosuppression.